miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. - Test2 - elhamkhani - TriplyDB

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

http://www.wikidata.org/entity/Q34448719

about

Structural and molecular features of intestinal strictures in rats with Crohn's-like disease Early detection of diabetic kidney disease: Present limitations and future perspectives microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?Key fibrogenic mediators: old players. Renin–angiotensin system TGF-β/Smad signaling in renal fibrosis Recent developments in myofibroblast biology: paradigms for connective tissue remodeling Smads as therapeutic targets for chronic kidney disease MicroRNAs in Diabetic Kidney Disease Regulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAs Function and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver Disease Epithelial-mesenchymal transition: An emerging target in tissue fibrosis Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases Human microRNAs profiling in response to influenza A viruses (subtypes pH1N1, H3N2, and H5N1)Mechanisms of fibrosis: therapeutic translation for fibrotic disease MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic Nephropathy microRNA in the development of diabetic complications.Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway.The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.The role of microRNAs in diabetic nephropathy.Transglutaminase II/microRNA-218/-181a loop regulates positive feedback relationship between allergic inflammation and tumor metastasis.Novel RNA-binding protein P311 binds eukaryotic translation initiation factor 3 subunit b (eIF3b) to promote translation of transforming growth factor β1-3 (TGF-β1-3).Functional implications of microRNA-215 in TGF-β1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1.Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cells.MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy The role of microRNAs in the pathogenesis of MMPi-induced skin fibrodysplasia.A genome-wide integrative study of microRNAs in human liver.microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model.MicroRNA-200a regulates Grb2 and suppresses differentiation of mouse embryonic stem cells into endoderm and mesoderm.Involvement of renal corpuscle microRNA expression on epithelial-to-mesenchymal transition in maternal low protein diet in adult programmed rats An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.Diabetes complications: the microRNA perspective.MicroRNAs in renal fibrosis.MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis.MicroRNA-21 in glomerular injury.Smad-mediated regulation of microRNA biosynthesis.

P2860

Q24658466-BCE9D6F4-6A73-432D-9BE5-069721264625 Q26741494-4F89BB3E-A1CB-4DA3-B1E6-C3EF92C1A197 Q26779972-6F45EA66-2533-4B5C-8C46-B1F8EAB03B84 Q26782283-8764AFED-6EAB-40F5-AD01-3CEF16C8F545 Q26796631-CE06B0C0-D1FC-4952-8627-3BC6A25B7147 Q26851198-61AD0512-86B6-4F6E-A800-AE66E3055E6D Q26863751-95C903AC-C36D-4735-8509-0808C0244494 Q26865998-43617B4F-2468-4E35-B2CC-87FD28CCAF30 Q27002171-8BE93DE4-BA00-4CDB-8238-5B71F5193B85 Q28072792-64765CFB-21E6-4544-A10A-62BA1A61E83B Q28073703-74D90E4D-1CDE-4029-BBB8-9C0F621D40E0 Q28083351-19AF3DFC-C407-45BA-BAF7-E7ABD28551B1 Q28297232-6467484A-C193-410E-8BDE-16541D2B33A3 Q28354033-F87D9D13-261C-4651-A819-67F53B5A259D Q28383462-21BEDA1E-8DA0-4D61-92FD-4A26FED4C1F1 Q29620307-B5520FA9-33FB-4AC8-AB15-E6C3A69CCABA Q30009025-8152362C-57E9-41C7-8DF3-4D1242FEF960 Q30353835-44BBA6DF-A65F-48F5-ADE3-165D92859C6D Q33714207-BB0F199E-0F9D-464F-9439-93A549F2DB48 Q33733403-3D3AB7B6-02BD-434C-A771-9FC0A7E82328 Q33806760-E7282506-538C-4AC2-B93E-102F54A247F5 Q33838714-DF1DE0A4-511C-4B05-816B-6292046B704B Q34170239-C4F84801-D66C-4655-919A-144808554C4D Q34195411-0C08293D-BD04-4647-9716-0904C90FBFA5 Q34396703-694CFFE8-C38F-4EC6-A03A-D1DF0FEFF077 Q34634172-B8EBF57C-20A8-4958-867D-38CE626DBB73 Q34648147-C9C1BB7C-FDDE-4401-868C-898B6B06F4EF Q34714698-703F6191-F98E-44FE-8503-B111252A8A40 Q34718910-9432814E-9FBD-4341-B873-8461CD438877 Q34728974-84E3946E-BCEF-4EEB-967D-61F7F66BA6BF Q34768681-DA64D44F-3034-4010-861C-795ADD027569 Q34792605-AA9FD4FF-C0E4-4D3D-996B-5E3D6FB5C64E Q34852344-5D111123-D6A0-4B99-888A-2AD01A5B563E Q34970854-A390CD2A-4E12-4880-9CC3-14D6352AE9D2 Q34977307-A305DA77-1CEC-448A-A623-47BD16FDCCBF Q35063237-915DF2C2-38F6-4C94-AFD1-1DD78943A640 Q35104478-F8483F63-4FC6-43F2-A838-40D89F0C7255 Q35185566-71E7CB3F-0486-4D02-9C90-2A4BC8FC27C4 Q35228513-350DEDC8-081A-41F6-857D-69F8A0F380ED Q35600535-7AA30358-B92A-4712-B461-057031E3E41F

P2860

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

http://www.wikidata.org/entity/Q34448719

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@ast

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@en

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@nl

type

label

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@ast

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@en

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@nl

prefLabel

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@ast

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@en

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@nl

P1433

Q34448719-56645C5B-4FCC-4EAB-A11C-790F887C5AFC

P1476

Q34448719-A7A86D63-6C0A-4C68-B72D-00C56945EA9E

P2093

Q34448719-2A2C1F25-A5D1-446A-95B7-71C89E27C5A8

Q34448719-2D9B0A1B-A5F8-41B1-9B70-21AFEFF0D586

Q34448719-776A4634-ACC3-4E9C-90A7-3195102A394E

Q34448719-7862A758-2D65-4D80-855E-6574E42E1F5A

Q34448719-B1A8A375-350A-4145-8FE2-C67EA104DD74

Q34448719-B2FA74C4-701D-4643-9361-FFFE68158AC9

Q34448719-B47AC5A3-004A-451D-B76F-557BE42A89AC

Q34448719-BAC08648-2368-4EB0-9FD2-12E54996E7B5

Q34448719-E897C2D5-B7EB-4DD0-BFF1-CA6B28240DE4

Q34448719-EE3C18DD-7E53-4EC2-AC1B-B75D3A3D7715

P2860

Q34448719-06281393-5B9C-4697-8875-528FFCF3359A

Q34448719-07A331C2-7ED3-43B3-9011-B16B20EACE08

Q34448719-08E50D18-9C0A-4ADA-8D59-48267B03BF3C

Q34448719-106BE49E-B884-4FCC-A981-881BEF8DFB9F

Q34448719-12674E44-F29B-44BE-B2A6-ECB96992C880

Q34448719-1FDC9F49-7AAE-4109-9D63-D73143B30592

Q34448719-243C467D-9D98-4594-87AA-AE2B33E478BB

Q34448719-5787909B-A4D0-4320-9158-A285CDAE9284

Q34448719-5AC8464E-4DA7-4A08-B996-F3ECA938AAE2

Q34448719-756C94FD-9761-40D6-876C-445874B6DD79

P304

Q34448719-0757DFE7-C8DD-4C3E-9744-600BBEB05D5E

P31

Q34448719-8AC8FCE0-F859-46DF-89A2-4D5D521CFFB0

P356

Q34448719-177ABF46-4021-4F4C-92EB-34C0AE1C17E3

P407

Q34448719-2DFD73B0-5D50-4033-A0A0-03260882C65B

P433

Q34448719-F209C02B-2C57-4224-9C1C-96E3D334A82A

P478

Q34448719-D7764E5A-78B8-466D-8107-646184AB6ED9

P50

Q34448719-82DB1920-58A5-4AF6-8947-0BFDBF580570

P577

Q34448719-2091263C-A3D2-40BC-960D-9EB4BFAD6F83

P5875

Q34448719-2977A0C9-BDC3-4337-8E3B-827DEE2CB878

P698

Q34448719-E8605781-8747-4AE8-8B1F-A42CF9BA5538

P932

Q34448719-EFC070AB-9E30-4F07-8106-2FE80DF0CEA4

P356

P1433

P1476

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.

@en

P2093

Aaron McClelland

http://www.w3.org/2001/XMLSchema#string

Bo Wang

http://www.w3.org/2001/XMLSchema#string

Catherine Winbanks

http://www.w3.org/2001/XMLSchema#string

Karin Jandeleit-Dahm

http://www.w3.org/2001/XMLSchema#string

Mark E Cooper

http://www.w3.org/2001/XMLSchema#string

Melinda T Coughlan

http://www.w3.org/2001/XMLSchema#string

Merlin C Thomas

http://www.w3.org/2001/XMLSchema#string

Philip Koh

http://www.w3.org/2001/XMLSchema#string

Phillip Kantharidis

http://www.w3.org/2001/XMLSchema#string

Wendy C Burns

http://www.w3.org/2001/XMLSchema#string

P2860

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro

TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Evidence that fibroblasts derive from epithelium during tissue fibrosis

Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA

P304

280-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB10-0892

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47449798

http://www.w3.org/2001/XMLSchema#string

P698

20952520

http://www.w3.org/2001/XMLSchema#string

P932

3012183

http://www.w3.org/2001/XMLSchema#string